Cargando…

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

BACKGROUND: We estimated the number of women undergoing cervical cancer screening annually in Italy, the rates of cervical abnormalities detected, and the costs of screening and management of abnormalities. METHODS: The annual number of screened women was estimated from National Health Interview dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Paolo Giorgi, Ricciardi, Alessandro, Cohet, Catherine, Palazzo, Fabio, Furnari, Giacomo, Valle, Sabrina, Largeron, Nathalie, Federici, Antonio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651166/
https://www.ncbi.nlm.nih.gov/pubmed/19243586
http://dx.doi.org/10.1186/1471-2458-9-71
_version_ 1782165143632740352
author Rossi, Paolo Giorgi
Ricciardi, Alessandro
Cohet, Catherine
Palazzo, Fabio
Furnari, Giacomo
Valle, Sabrina
Largeron, Nathalie
Federici, Antonio
author_facet Rossi, Paolo Giorgi
Ricciardi, Alessandro
Cohet, Catherine
Palazzo, Fabio
Furnari, Giacomo
Valle, Sabrina
Largeron, Nathalie
Federici, Antonio
author_sort Rossi, Paolo Giorgi
collection PubMed
description BACKGROUND: We estimated the number of women undergoing cervical cancer screening annually in Italy, the rates of cervical abnormalities detected, and the costs of screening and management of abnormalities. METHODS: The annual number of screened women was estimated from National Health Interview data. Data from the Italian Group for Cervical Cancer Screening were used to estimate the number of positive, negative and unsatisfactory Pap smears. The incidence of CIN (cervical intra-epithelial neoplasia) was estimated from the Emilia Romagna Cancer Registry. Patterns of follow-up and treatment costs were estimated using a typical disease management approach based on national guidelines and data from the Italian Group for Cervical Cancer Screening. Treatment unit costs were obtained from Italian National Health Service and Hospital Information System of the Lazio Region. RESULTS: An estimated 6.4 million women aged 25–69 years undergo screening annually in Italy (1.2 million and 5.2 million through organized and opportunistic screening programs, respectively). Approximately 2.4% of tests have positive findings. There are approximately 21,000 cases of CIN1 and 7,000–17,000 cases of CIN2/3. Estimated costs to the healthcare service amount to €158.5 million for screening and €22.9 million for the management of cervical abnormalities. CONCLUSION: Although some cervical abnormalities might have been underestimated, the total annual cost of cervical cancer prevention in Italy is approximately €181.5 million, of which 87% is attributable to screening.
format Text
id pubmed-2651166
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26511662009-03-05 Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy Rossi, Paolo Giorgi Ricciardi, Alessandro Cohet, Catherine Palazzo, Fabio Furnari, Giacomo Valle, Sabrina Largeron, Nathalie Federici, Antonio BMC Public Health Research Article BACKGROUND: We estimated the number of women undergoing cervical cancer screening annually in Italy, the rates of cervical abnormalities detected, and the costs of screening and management of abnormalities. METHODS: The annual number of screened women was estimated from National Health Interview data. Data from the Italian Group for Cervical Cancer Screening were used to estimate the number of positive, negative and unsatisfactory Pap smears. The incidence of CIN (cervical intra-epithelial neoplasia) was estimated from the Emilia Romagna Cancer Registry. Patterns of follow-up and treatment costs were estimated using a typical disease management approach based on national guidelines and data from the Italian Group for Cervical Cancer Screening. Treatment unit costs were obtained from Italian National Health Service and Hospital Information System of the Lazio Region. RESULTS: An estimated 6.4 million women aged 25–69 years undergo screening annually in Italy (1.2 million and 5.2 million through organized and opportunistic screening programs, respectively). Approximately 2.4% of tests have positive findings. There are approximately 21,000 cases of CIN1 and 7,000–17,000 cases of CIN2/3. Estimated costs to the healthcare service amount to €158.5 million for screening and €22.9 million for the management of cervical abnormalities. CONCLUSION: Although some cervical abnormalities might have been underestimated, the total annual cost of cervical cancer prevention in Italy is approximately €181.5 million, of which 87% is attributable to screening. BioMed Central 2009-02-25 /pmc/articles/PMC2651166/ /pubmed/19243586 http://dx.doi.org/10.1186/1471-2458-9-71 Text en Copyright © 2009 Rossi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Rossi, Paolo Giorgi
Ricciardi, Alessandro
Cohet, Catherine
Palazzo, Fabio
Furnari, Giacomo
Valle, Sabrina
Largeron, Nathalie
Federici, Antonio
Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy
title Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy
title_full Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy
title_fullStr Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy
title_full_unstemmed Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy
title_short Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy
title_sort epidemiology and costs of cervical cancer screening and cervical dysplasia in italy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651166/
https://www.ncbi.nlm.nih.gov/pubmed/19243586
http://dx.doi.org/10.1186/1471-2458-9-71
work_keys_str_mv AT rossipaologiorgi epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly
AT ricciardialessandro epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly
AT cohetcatherine epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly
AT palazzofabio epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly
AT furnarigiacomo epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly
AT vallesabrina epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly
AT largeronnathalie epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly
AT federiciantonio epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly